Emla® cream-induced allergic contact dermatitis in a child with thalassaemia major

Contact Dermatitis

Volumn 52, Issue 2, 2005, Pages 111-

  Ismail, F ^a   Goldsmith, P C ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Allergic contact dermatitis; Children; Emla cream; Medicaments; Prilocaine

Indexed keywords

4 HYDROXYBENZOIC ACID ESTER; CARBOMER; CINCHOCAINE; DEFEROXAMINE; EMLA; LIDOCAINE; PRILOCAINE; TETRACAINE; ALLERGEN; IRON CHELATING AGENT; LOCAL ANESTHETIC AGENT;

ANAMNESIS; ARTICLE; CASE REPORT; DRUG ERUPTION; DRUG HYPERSENSITIVITY; ECZEMA; HUMAN; MALE; PATCH TEST; SCHOOL CHILD; SKIN ALLERGY; THALASSEMIA MAJOR; ABDOMEN; BETA THALASSEMIA; CHILD; DIFFERENTIAL DIAGNOSIS; PATHOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION;

ABDOMEN; ALLERGENS; ANESTHETICS, LOCAL; BETA-THALASSEMIA; CHILD; DEFEROXAMINE; DERMATITIS, ALLERGIC CONTACT; DIAGNOSIS, DIFFERENTIAL; HUMANS; INJECTIONS, SUBCUTANEOUS; IRON CHELATING AGENTS; LIDOCAINE; MALE; PATCH TESTS; PRILOCAINE;

EID: 20344395874     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-1873.2005.00498e.x     Document Type: Article

References (4)

1. Summary of Product Characteristics Emla® cream 5%, Astra Zeneca, August 2002.
2. Van den Hove J, Decroix J, Tennstedt D et al. Allergic contact dermatitis from prilocaine, one of the local anaesthetics in Emla® cream. Contact Dermatitis 1994: 30: 239.
3. Thakur B K, Murali M R. Emla® cream induced allergic contact dermatitis: a role for prilocaine as an immunogen. J Allergy Clin Immunol 1995: 95: 776-778.
4. Le Coz C J, Cribier B J, Heid E. Patch testing in suspected allergic contact dermatitis due to Emla® cream in haemodialyzed patients. Contact Dermatitis 1996: 35: 316-317.